The agreement will open markets in Denmark, Sweden, and Norway for SpeeDx's STI detection product lines.
In an increasingly diverse field of sequencing assays, Genentech researchers believe they have achieved notable sensitivity, with high multiplexing capability and relatively low cost.
ExcitePCR's technology detects pathogens in 30 minutes or less using a backpack-sized device, integrating sample prep with PCR and RIF technology in a disposable cartridge.
The financing follows Cofactor's launch of Pinnacle, an RNA-based oncology assay and the company's first product since a strategic refocusing.
The thermocycler is a point-of-care diagnostic system that enables real-time molecular testing in hospitals, clinics, physician offices, and the field.
The kit detects 29 mutations in exons 18, 19, 20, and 21, and has a limit of mutation detection at .1 percent in a background of wild-type DNA.
The university's new court documents allege that Life Tech, its co-plaintiff in the previous suit, "fraudulently" induced it to settle the case against Illumina.
The scientists hope to incorporate the method, which can measure endogenous peptides at zeptomolar concentrations, in clinical trials starting next year.
Curetis and BGI subsidiary MGI Tech plan to develop NGS-based diagnostics for microbial infections on the MGISeq instrument for the Chinese market.
A study presented at the National Society of Genetic Counselors meeting examined experiences of parents whose children underwent exome sequencing.
Additional studies and reanalyses can reclassify variants of unknown significance, speakers at the National Society of Genetic Counselors meeting said.
The team used CRISPR to inactivate a gene in colon organoids, and found that a specific DNA repair defect underlies a mutational signature in some cancers.
Researchers identified unique ALK rearrangements in patients that lack previously known indicators of mesothelioma.
Data from hundreds of individuals suggest that the country's populations are genetically diverse, with a long history of genetic isolation and differentiation.
Tempus will provide molecular sequencing and data analysis for patients with metastatic or incurable cancer enrolled in a Cleveland Clinic study.
The firm now intends to set up an internal laboratory to experiment with different compounds, while building out its team.
GenomeDx will have exclusive rights to distribute the molecular tests in most of the US, while Pathnostics continues to perform the assays in-house.
PerkinElmer Genetics will provide clinical whole-genome sequencing, data interpretation, and diagnostic reports to IDG for patients with neurological disorders.
Investigators compared RNA sequence data in heart samples from individuals with dilated cardiomyopathy and samples from healthy transplant donor hearts.
The deal will join the AmbryPort 2.0 clinical ordering platform with FDNA's Face2Gene next-generation phenotyping application suite.
While gene therapies may have high price tags, they could be cheaper than the cost of managing disease, according to MIT's Technology Review.
Researchers are looking for markers that indicate which cancer patients may respond to immunotherapies, the Associated Press writes.
In Nature this week: paternal age associated with de novo mutations in children, and more.
Nature News writes that researchers are still wrangling over the role of the p-value.